Smith & Nephew plc (NYSE: SNN)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Smith & Nephew plc Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Smith & Nephew plc Company Info
News & Analysis
The pandemic hit Zimmer, Smith+Nephew, and Stryker hard -- but they'll soon rise again.
Some of the biggest medical device companies' stocks have dropped to attractive prices due to the current COVID-19 pandemic.
Its chief executive's sudden exit sent the stock reeling.
The rumor mill is buzzing about a potential takeover offer. Here's what investors need to know.
On a sunny day for the market, these stocks gained ground. Find out why.
Looking for solid dividend stocks in the medical device industry? Check out Abbott Labs, Medtronic, and Smith & Nephew.
Smith & Nephew's stock recedes from recent highs as investors continue to circle the possibility of a takeover for this medical-device maker
As health-care multinational corporations look to cut costs, companies in these three tax havens could be ripe takeover targets.
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Valuation
Earnings Transcripts
SNN earnings call for the period ending September 30, 2021.
SNN earnings call for the period ending April 3, 2021.
SNN earnings call for the period ending December 31, 2020.
SNN earnings call for the period ending September 30, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.